UPCI Appoints Director of Newly Formed Women’s Cancer Research Center
PITTSBURGH, Sept. 1, 2010 – Adrian V. Lee, Ph.D., a renowned expert in the molecular and cellular biology of breast cancer, has been appointed director of the newly formed Women’s Cancer Research Center at the University of Pittsburgh Cancer Institute (UPCI) and Magee-Womens Research Institute (MWRI). His appointment was effective Aug. 1.
“I’ve known Dr. Lee for a long time, and I am thrilled he is joining our team,” said Nancy E. Davidson, M.D., director of UPCI and UPMC Cancer Centers. “Dr. Lee’s background in cancer research, as well as his leadership skills and his dedication to finding new ways to prevent and treat women’s cancers, will significantly enhance our efforts to advance the basic, translational and clinical aspects of a developing women’s cancer program.”
Before joining UPCI, Dr. Lee was an associate professor of medicine and molecular and cellular biology in the Departments of Medicine and Molecular and Cellular Biology at Baylor College of Medicine in Houston.
Dr. Lee is especially well-known for his work targeting growth factor pathways as a potential new approach to breast cancer treatment. He has reported his work in nearly 100 publications, and his studies have been funded by the National Cancer Institute, the Department of Defense, Howard Hughes Medical Institute and multiple foundations, including Susan G. Komen for the Cure. Dr. Lee serves as the section or associate editor of the journals Breast Cancer Research; Hormones and Cancer; and Hormone Molecular Biology and Clinical Investigation. Dr. Lee was recently appointed to the Scientific Advisory Council of Susan G. Komen for the Cure and has served on numerous scientific review panels. He is a permanent member of the molecular oncogenesis section for the National Institutes of Health.
Dr. Lee received his doctorate from the University of Surrey in England and completed a postdoctoral fellowship in the Department of Medicine at the University of Texas Health Science Center in San Antonio.
“As director of the new Women’s Cancer Research Center, Dr. Lee will employ his considerable skills as a leader, researcher and mentor to enrich ongoing joint research efforts at UPCI and MWRI in the fields of breast and gynecological cancers,” said Yoel Sadovsky, M.D., director of MWRI. “We anticipate exciting new collaborations among our scientists as they address key questions in this area of women’s health.”
“I am honored to be given the chance to direct the new Women’s Cancer Research Center,” said Dr. Lee. “The goal of this center is to perform bench-to-bedside research and translate laboratory findings into clinical advances in the prevention and treatment of women’s cancers. Given the outstanding clinical and basic science in women’s cancer at UPCI and MWRI, we expect to have a rapid and major impact on reducing the burden of these diseases.”
As the only NCI-designated comprehensive cancer center in western Pennsylvania, UPCI is a recognized leader in providing innovative cancer prevention, detection, diagnosis, and treatment; biomedical research; compassionate patient care and support; and community-based outreach services. UPCI investigators are world-renowned for their work in clinical and basic cancer research.